The global biotechnological kits market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include the increase in inherited diseases and technological advancements. Biotechnological kits have broad applications such as detecting genetic disorders and various chronic illnesses, food residues, and cell culture, which upsurges demand and drives the market growth. Also, multiple advancements are done to increase these kits' efficiency and produce new products, which is projected to propel the growth of the biotechnological kits market. The other factors supporting the market's growth are increasing technological investments by leading companies, funding of research and development (R&D) projects by governments, and wide application of biotechnological kits in various fields such as pharmaceutical industries, food industries, and agriculture and bioinformatics.
Increasing Investments in Biotechnological Sector
Heavy investments in the biotechnological sector by the government and leading biotech companies are expected to boost the growth of the biotechnological kits market globally. With the increasing investments, biotechnological kits are upgraded and made more efficient. Also, the biotech and pharmaceutical companies' expansion is anticipated to significantly increase the biotechnological kits market's growth. Governments have taken initiatives such as the research and developments (R&D) projects which are being funded to build effective and efficient kits which are going to fuel the growth of the market.
Increase in Inherited Diseases
Nowadays, people are suffering from various genetic disorders, which has propelled the adoption of molecular diagnostics. Key processes of molecular diagnostics such as polymerase chain reaction (PCR) and epigenetics need molecular biological kits. The rise in population has also increased the demand for biotechnological kits as people are suffering from various inherited and non-inherited diseases. Additionally, the occurrence of pandemics and epidemics is also driving the growth of the biotechnological kits market. For example, during the outbreak of COVID-19, RT-PCRs were used to detect the viral RNAs in the patients, which resulted in using the purification kits. Also, numerous diagnosis tests were developed to detect COVID-19 and its variant, which augmented the growth of the market.
Increase in Technological Advancements
Over the past few years, immense growth and developments have been witnessed in the biotechnological kits market to make them more accurate, time-saving, and highly sensitive. An increase in technological advancements such as tissue engineering, fermentation, DNA sequencing, and recombinant technology is likely to bolster the growth of the market. Besides, the advancements, adoption and intersection of the technologies are expected to witness the lucrative growth of the biological kits market. Technological advancements in molecular diagnostic techniques (genome-wide sequencing, droplet digital PCR, and NGS), biotechnological field, cell culture, and growing biomolecular applications are propelling the demand for biotechnological kits. Thus, in turn, the biotechnological kits market is predicted to grow exponentially in upcoming years. For instance, the launch of the SMART Digest Kit by Thermo Fisher Scientific, Inc., especially aimed at biopharmaceutical applications and proteomic applications
Market Segmentation
Market Players
Thermo Fischer Scientific, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Merck KGaA, Promega Corporation, Takara Bio, Inc, and New England Biolabs UK Limited
Attribute | Details |
Base Year | 2021 |
Historic Data | 2017 – 2020 |
Estimated Year | 2022 |
Forecast Period | 2023 – 2027 |
Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Kit Type · Technology · Parameter Tested · Microorganism · Purpose · End User · Company |
Regional scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa |
Key companies profiled | Thermo Fischer Scientific, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Merck KGaA, Promega Corporation, Takara Bio, Inc, New England Biolabs UK Limited |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |